120 related articles for article (PubMed ID: 31103261)
1. Clinically relevant concentration of sevoflurane suppresses cervical cancer growth and migration through targeting multiple oncogenic pathways.
Ding J; Zhang L; Zeng S; Feng T
Biochem Biophys Res Commun; 2019 Jul; 514(4):1179-1184. PubMed ID: 31103261
[TBL] [Abstract][Full Text] [Related]
2. Inhibiting 6-phosphogluconate dehydrogenase enhances chemotherapy efficacy in cervical cancer via AMPK-independent inhibition of RhoA and Rac1.
Guo H; Xiang Z; Zhang Y; Sun D
Clin Transl Oncol; 2019 Apr; 21(4):404-411. PubMed ID: 30182212
[TBL] [Abstract][Full Text] [Related]
3. The Effects Of Sevoflurane On The Progression And Cisplatinum Sensitivity Of Cervical Cancer Cells.
Xue F; Xu Y; Song Y; Zhang W; Li R; Zhu X
Drug Des Devel Ther; 2019; 13():3919-3928. PubMed ID: 31819366
[TBL] [Abstract][Full Text] [Related]
4. Sevoflurane Enhances Proliferation, Metastatic Potential of Cervical Cancer Cells via the Histone Deacetylase 6 Modulation In Vitro.
Zhang W; Sheng B; Chen S; Zhao H; Wu L; Sun Y; Cui J; Zhu X; Ma D
Anesthesiology; 2020 Jun; 132(6):1469-1481. PubMed ID: 32412720
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxicity of amide-linked local anesthetics on melanoma cells via inhibition of Ras and RhoA signaling independent of sodium channel blockade.
Zheng Q; Peng X; Zhang Y
BMC Anesthesiol; 2020 Feb; 20(1):43. PubMed ID: 32085741
[TBL] [Abstract][Full Text] [Related]
6. Metformin Inhibit Cervical Cancer Migration by Suppressing the FAK/Akt Signaling Pathway.
Hakimee H; Hutamekalin P; Tanasawet S; Chonpathompikunlert P; Tipmanee V; Sukketsiri W
Asian Pac J Cancer Prev; 2019 Dec; 20(12):3539-3545. PubMed ID: 31870092
[TBL] [Abstract][Full Text] [Related]
7. Ras inhibition by zoledronic acid effectively sensitizes cervical cancer to chemotherapy.
Xu J; Pan Q; Ju W
Anticancer Drugs; 2019 Sep; 30(8):821-827. PubMed ID: 30882399
[TBL] [Abstract][Full Text] [Related]
8. RAS and RHO family GTPase mutations in cancer: twin sons of different mothers?
Hodge RG; Schaefer A; Howard SV; Der CJ
Crit Rev Biochem Mol Biol; 2020 Aug; 55(4):386-407. PubMed ID: 32838579
[TBL] [Abstract][Full Text] [Related]
9. Ras inhibitors display an anti-metastatic effect by downregulation of lysyl oxidase through inhibition of the Ras-PI3K-Akt-HIF-1α pathway.
Yoshikawa Y; Takano O; Kato I; Takahashi Y; Shima F; Kataoka T
Cancer Lett; 2017 Dec; 410():82-91. PubMed ID: 28951129
[TBL] [Abstract][Full Text] [Related]
10. Zoledronic acid inhibits the growth of cancer stem cell derived from cervical cancer cell by attenuating their stemness phenotype and inducing apoptosis and cell cycle arrest through the Erk1/2 and Akt pathways.
Wang L; Liu Y; Zhou Y; Wang J; Tu L; Sun Z; Wang X; Luo F
J Exp Clin Cancer Res; 2019 Feb; 38(1):93. PubMed ID: 30791957
[TBL] [Abstract][Full Text] [Related]
11. Sevoflurane inhibits growth factor-induced angiogenesis through suppressing Rac1/paxillin/FAK and Ras/Akt/mTOR.
Wang X; Yao Y; Gao J
Future Oncol; 2020 Aug; 16(22):1619-1627. PubMed ID: 32479124
[No Abstract] [Full Text] [Related]
12. Overexpression of RhoA promotes the proliferation and migration of cervical cancer cells.
Liu X; Chen D; Liu G
Biosci Biotechnol Biochem; 2014; 78(11):1895-901. PubMed ID: 25104222
[TBL] [Abstract][Full Text] [Related]
13. Raf and RhoA cooperate to transform intestinal epithelial cells and induce growth resistance to transforming growth factor beta.
Du J; Jiang B; Coffey RJ; Barnard J
Mol Cancer Res; 2004 Apr; 2(4):233-41. PubMed ID: 15140945
[TBL] [Abstract][Full Text] [Related]
14. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
[TBL] [Abstract][Full Text] [Related]
15. Ropivacaine inhibits the migration of esophageal cancer cells via sodium-channel-independent but prenylation-dependent inhibition of Rac1/JNK/paxillin/FAK.
Zhang Y; Peng X; Zheng Q
Biochem Biophys Res Commun; 2018 Jul; 501(4):1074-1079. PubMed ID: 29777701
[TBL] [Abstract][Full Text] [Related]
16. Blocking Modification of Eukaryotic Initiation 5A2 Antagonizes Cervical Carcinoma via Inhibition of RhoA/ROCK Signal Transduction Pathway.
Liu X; Chen D; Liu J; Chu Z; Liu D
Technol Cancer Res Treat; 2017 Oct; 16(5):630-638. PubMed ID: 27609633
[TBL] [Abstract][Full Text] [Related]
17. HRAS as a potential therapeutic target of salirasib RAS inhibitor in bladder cancer.
Sugita S; Enokida H; Yoshino H; Miyamoto K; Yonemori M; Sakaguchi T; Osako Y; Nakagawa M
Int J Oncol; 2018 Aug; 53(2):725-736. PubMed ID: 29901113
[TBL] [Abstract][Full Text] [Related]
18. Impact of Cellular Genetic Make-up on Colorectal Cancer Cell Lines Response to Ellagic Acid: Implications of Small Interfering RNA.
Yousef AI; El-Masry OS; Abdel Mohsen MA
Asian Pac J Cancer Prev; 2016; 17(2):743-8. PubMed ID: 26925673
[TBL] [Abstract][Full Text] [Related]
19. Gα12/13 signaling promotes cervical cancer invasion through the RhoA/ROCK-JNK signaling axis.
Yuan B; Cui J; Wang W; Deng K
Biochem Biophys Res Commun; 2016 May; 473(4):1240-1246. PubMed ID: 27084452
[TBL] [Abstract][Full Text] [Related]
20. Artepillin C Induces Selective Oxidative Stress and Inhibits Migration and Invasion in a Comprehensive Panel of Human Cervical Cancer Cell Lines.
Souza RP; Bonfim-Mendonça PS; Damke GMZF; de-Assis Carvalho ARB; Ratti BA; Dembogurski DSO; da-Silva VRS; Silva SO; Da-Silva DB; Bruschi ML; Maria-Engler SS; Consolaro MEL
Anticancer Agents Med Chem; 2018; 18(12):1750-1760. PubMed ID: 29866020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]